Cipla Health signs agreement to acquire Endura Mass
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Company hires life science veteran Jessica Cao to join management team
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
This new fund is amongst the largest for the sector in India
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA
Subscribe To Our Newsletter & Stay Updated